Sanggenon E



Compound IDCDAMM02025
Common nameSanggenon E
IUPAC name2-[6-[2,4-dihydroxy-3-(3-methylbut-2-enyl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-1,3,5a,8-tetrahydroxy-10a-(3-methylbut-2-enyl)-[1]benzofuro[3,2-b]chromen-11-one
Molecular formulaC45H44O12

Experimental data

Retention time19.42
Adduct[M+H]+
Actual mz777.29
Theoretical mz777.29
Error0.23
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.2757

Identifiers and class information

Inchi keyCUJJTBMGUHNKPO-GXQCSOQPNA-N
SmilesO=C(C1=CC=C(O)C(=C1O)CC=C(C)C)C2C(C=C(C)CC2C3=CC=C(O)C=C3O)C4=C(O)C=C5OC6(O)C7=CC=C(O)C=C7OC6(C(=O)C5=C4O)CC=C(C)C
SuperclassPhenylpropanoids and polyketides
ClassDiarylheptanoids

Pharmacokinetic properties

Number of descriptor values(#stars)10
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)14
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)776.835
Computed dipole moment(dipole)4.236
Total solvent accessible surface area (SASA)1026.61
Hydrophobic component of SASA (FOSA)450.928
Hydrophilic component of SASA (FISA)286.091
Pie component of the SASA (PISA)289.591
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2114.37
Number of hydrogen bond donors (donorHB)6
Number of hydrogen bond acceptors (accptHB)9.5
Free energy of solvation of dipole (dip^2/V)0.0084877
Index of cohesive interaction in solids (ACxDN^.5/SA)0.022667
Globularity descriptor (glob)0.776033
Predicted polarizability in cubic angstroms (QPpolrz)72.239
Predicted hexadecane/gas partition coefficient (QPlogPC16)23.067
Predicted octanol/gas partition coefficient (QPlogPoct)39.136
Predicted water/gas partition coefficient (QPlogPw)21.163
Predicted octanol/water partition coefficient (QPlogPo/w)6.028
Predicted aqueous solubility (QPlogS)-8.274
Conformation-independent predicted aqueous solubility (CIQPlogS)-12.372
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.537
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)19.182
Predicted brain/blood partition coefficient (QPlogBB)-3.447
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)6.892
Predicted skin permeability, log Kp (QPlogKp)-4.428
PM3 calculated ionization potential (IP(ev))8.954
PM3 calculated electron affinity (EA(eV))0.562
Number of likely metabolic reactions (#metab)18
Prediction of binding to human serum albumin (QPlogKhsa)1.494
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)33.368
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)214.489
Number of nitrogen and oxygen atoms (#NandO)12
Number of violations of Lipinski’s rule of five (RuleOfFive)4
Number of violations of Jorgensen’s rule of three (RuleOfThree)3

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P18031PTPN1Protein-tyrosine phosphatase 1BT16347SwissTargetPrediction
P14679TYRTyrosinaseT97035SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16347DI0009Acute diabete complication[ICD-11: 5A2Y]P18031PTPN1
T16347DI0062Breast cancer[ICD-11: 2C60-2C6Y]P18031PTPN1
T16347DI0308Obesity[ICD-11: 5B80-5B81]P18031PTPN1
T16347DI0417Type 2 diabetes mellitus[ICD-11: 5A11]P18031PTPN1
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR

Copyright © 2025